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Comparative anticancer activity of dolaborane diterpenes from the roots of 










This study aimed at investigating the anticancer activity of tagalsins A, B, C, D, E, F and G isolated from 
the roots of Ceriops tagal. Their structures were established based on the IR, MS and NMR spectral data. 
Anticancer activity was evaluated using caspase-3 colourimetric assays and the minimum activation 
concentrations were established. The study revealed that tagalsin A, B, C, D, E, F and G induces apoptosis 
through the activation of caspase-3 enzyme. Tagalsin A was the most active (MAC value of 0.12 µg/mL) 
followed by tagalsin B (MAC of 0.15 µg/mL) and and tagalsin E was the least active (MAC value of 1.16 
µg/mL). Structure activity relationship revealed that epoxide rings and oxygenation enhanced the activity of 
tagalsins in inducing caspase-3 activation of apoptotic pathway, thus, providing an avenue for the development 
of anticancer agents with novel mechanism of actions. 
© 2012 International Formulae Group. All rights reserved. 
 




One of the hallmarks of cancer is its 
resistance to apoptosis which is important in 
the development and maintenance of higher 
organisms (Hanahan and Weinberg, 2000). 
This resistance enables cancerous cells to 
survive and divide even in the presence of 
endogenous proapoptotic stimuli (Peterson et 
al., 2009). In human cells, apoptosis involves 
the activation of a unique family of proteases, 
the caspases (cysteine-containing 
aspartatespecific proteases) which plays a 
central role in initiation and execution of the 
apoptotic process. The caspases are 
constitutively expressed in all cell types as 
zymogens, or procaspases, that has to be 
proteolytically cleaved to become active 
enzymes. Unlike normal cells, cancerous cells 
evades apoptosis through variety of 
mechanisms involving mutation or altered 
expression levels of key proteins in the 
apoptotic cascade (Igney and Krammer, 2002; 
Lowe et al., 2004) including mutation of p53 
(Vogelstein and Kinzler, 2001), elevated 
expression of the antiapoptotic proteins in the 
Bcl-2 family (Kirkin et al., 2004) and 
inactivation of Apaf-1 (Soengas et al., 2001). 
The net result of these alterations is a 
resistance to apoptosis, allowing for 
unchecked cellular proliferation.  
The direct induction of apoptosis has 
therefore emerged as a powerful anticancer 
strategy, and compounds that activate caspase 
enzymes in the apoptotic pathway have great 





potential as novel chemotherapeutic agents. It 
is in this vein that tagalsin A (1), B (2), C (3), 
D (4), E (5), F (6) and G (7) isolated from the 
roots of Ceriops tagal were evaluated for 
anticancer activity using caspase-3 
calorimetric assay.  
 
MATERIALS AND METHODS 
General  
NMR spectra were determined on a 
Bruker Avance DRX 600 and referenced to 
residual solvent signals. Low-resolution mass 
spectra were obtained on Finnigan MAT 
LCQDECA instrument and high resolution mass 
spectra were obtained on GCT Premier 
Instrument. The ultraviolet and visible (UV-
VIS) spectra were taken on Shimadzu UV-
2101PC UV-Vis Scanning Spectrophotometer. 
Infrared (IR) absorptions were measured on a 
Perkins Elmer System 2000 FT-IR 
Spectrophotometer using KBr pellets. Specific 
rotations  were measured on polatronic-
D (Schmidt + Haensch) polarimeter. Melting 
points were recorded using Stuart Scientific 
melting point apparatus and are uncorrected.  
 
Plant material 
The roots of Ceriops tagal were 
collected from Kisakasaka Mangrove Reserve, 
Zanzibar, Tanzania. The plant species was 
identified by Mtumwa Mhidini of the Institute 
of Marine Sciences, University of Dar es 
Salaam. A voucher specimen (CTM-104) was 
deposited at the laboratory of Natural Products 
and Biotechnology of the Institute of Marine 
Sciences, University of Dar es Salaam. 
 
Extraction, isolation and identification of 
compounds 
The roots of Ceriops tagal were air 
dried and then pulverized. The powdered 
sample (3.8 Kg) was extracted using CHCl3 
thrice at room temperature and the extract 
concentrated in vacuum to give a brown 
residue. The extract (22 g) was adsorbed in 
silica gel, loaded on a silica gel 
chromatographic column and eluted with n-
hexane-CHCl3 as a gradient to obtain twelve 
fractions which were combined based on the 
TLC analysis. Fraction B (1.34 g) was 
adsorbed in silica gel and applied to a silica 
gel column eluted with n-hexane/Et2O (13:1.5) 
to obtain tagalsin F (6) (132 mg). Fraction D 
(0.8 g) was subjected to a Sephadex® LH-20 
column and eluted with CHCl3–MeOH (1:1) 
to give tagalsins E (5) (17 mg), C (3) (18.6 
mg) and G (7) (14.2 mg). Fraction E (60 mg, 
10:1) was adsorbed in silica gel and loaded on 
the silica gel column and eluted with n-
hexane/Et2O (8:1) to afford tagalsins A (1) 
(16.6 mg), B (2) (19.5 mg), and D (4) (14.2 
mg). Tagalsin A (1) was recrystallized as 
needles from acetone. 
 
Spectral data of dolaboranes 1, 2, 3, 4, 5, 6 
and 7 
Tagalsin A (1)  
Pale yellow needle crystals. m.p. 68–71 
°C;  +69.24o (c0.052, CHCl3); IR (KBr) 
υmax 3409, 2859, 1672, 1412 cm
-1; EI-MS m/z 
(%): 316 [M]+ (15), 286 (17), 259 (20), 179 
(27), 163 (53), 136 (100), 107 (93); 
HRFABMS m/z 317.21110 [M + H]+ (calcd 
for C20H29O3, 317.21111). 
1H-NMR δ (ppm): 
6.35 (1H, d, J = 6.8 Hz, H-1), 5.80 (1H, dd, J 
= 10.5, 17.5 Hz, H-15), 4.93 (1H, d J = 17.5 
Hz, H-16), 4.85 (1H, d, J = 10.5 Hz, H-16), 
3.43 (1H, d, J = 6.0 Hz, H-18), 2.95 (1H, d, J 
= 6.0 Hz, H-18), 2.15 (1H, d, J = 6.8 Hz, H-
10), 1.52 (1H, ddd, J = 3.0, 4.0, 12.5 Hz, H-
11), 1.48 (2H, m, H-7, 12), 1.45 (1H, m, H-6), 
1.41 (1H, dd, J = 10.5, 12.5 Hz, H-11), 1.34 
(1H, dd, J = 11.5, 12.5 Hz, H-14), 1.21 (1H, 
dd, J =3.0, 14.0 Hz, H-12), 1.18 (1H, m, H-6), 
1.17 (1H, s, H-19), 1.06 (1H, m, H-7), 1.05 
(1H, m, H-17), 1.02 (1H, m, H-14), 0.79 (1H, 
s, H-20). 13C-NMR δ (ppm): 190.8 (C-3), 
150.3 (C-15), 146.9 (C-2), 120.8 (C-1), 108.5 
(C-16), 60.3 (C-4), 54.5 (C-10), 50.4 (C-18), 
40.6 (C-8), 39.8 (C-9), 39.5 (C-14), 36.4 (C-
13), 35.9 (C-5), 34.9 (C-11), 33.9 (C-6), 31.8 
(C-12), 31.6 (C-19), 27.3 (C-7), 22.8 (C-17), 









Tagalsin B (2) 
White solid. m.p. 66–69 °C;   
+164o (c0.05, CHCl3); IR (KBr) υmax 3430, 
2922, 2853, 1681, 1636, 1599, 1219. EIMS 
m/z (%): 316 [M]+ (17), 283 (20), 255 (18), 
175 (49), 136 (63), 107 (100), 81 (69), 67 
(43), 55 (50); HRFABMS m/z 317.2110 [M + 
H]+ (calcd for C20H29O3 317.2111). 
1H-NMR δ 
(ppm): 6.31 (1H, d, J = 6.5 Hz, H-1), 5.87 
(1H, dd, J = 10.5, 17.5Hz, H-15), 4.92 (1H, d
J = 17.5 Hz, H-16), 4.85 (1H, d, J = 10.5 Hz, 
H-16), 3.13 (1H, d, J = 6.0 Hz, H-18), 3.09 
(1H, d, J = 6.0 Hz, H-18), 2.19 (1H, d, J = 6.5 
Hz, H-10), 1.60 (1H, m, H-6), 1.56 (1H, m, H-
11), 1.46 (2H, m, H-8, 12), 1.43 (1H, m, H-
11), 1.34 (1H, dd, J = 13.0, 13.5 Hz, H-14), 
1.25 (1H, m, H-12), 1.23 (1H, m, H-7), 1.21 
(1H, s, H-19), 1.18 (2H, m, H-6, 7), 1.05 (1H, 
s, H-17), 0.72 (1H, s, H-20). 13C-NMR δ 
(ppm): 191.8 (C-3), 150.3 (C-15), 147.3 (C-2), 
120.2 (C-1), 108.6 (C-16), 61.3 (C-4), 54.8 
(C-10), 55.4 (C-18), 40.1 (C-8), 39.3 (C-14), 
39.0 (C-9), 36.9 (C-5), 35.9 (C-13), 34.7 (C-
11), 31.9 (C-6), 31.7 (C-12), 29.5 (C-19), 27.0 
(C-7), 22.7 (C-17), 13.1 (C-20).  
 
Tagalsin C (3)  
Yellow oil.  +92.3o (c0.05; 
CHCl3); IR (KBr) υmax 3403, 3082, 2924, 
2859, 1662, 1605, 1459, 1411, 1220, 1082 cm-
1; EI-MS m/z (%): 300 [M]+ (26), 163 (35), 
151 (45), 138 (77), 107 (100), 93 (60), 79 
(77); HRFABMS m/z 301.2162 [M + H]+ 
(calcd for C20H29O2, 301.2162).
 1H-NMR δ 
(ppm): 6.26 (1H, brs, H-18b), 6.22 (1H, d, J = 
6.7 Hz, H-1), 5.80 (1H, dd, J = 17.5, 10.8 Hz, 
H-15), 5.43 (1H, brs, H-18a), 4.90 (1H, d, J = 
17.5 Hz, H-16b), 4.87 (1H, d, J = 10.8 Hz, H-
16a), 2.20 (1H, ddd, J = 14.5, 2.5, 2.5 Hz, H- 
6b), 2.08 (1H, d, J = 6.7 Hz, H-10), 1.48 (1H, 
m, H-6a & H-12b),  1.53 (1H, m, H-11b), 1.46 
(1H, m, H-8), 1.34 (1H, m, H-11a), 1.32 (1H, 
m, H-7b), 1.20 (1H, m, H-7a & H-12a), 1.30 
(1H, m, H-14b), 1.10 (1H, m, H-14a), 1.14 
(3H, s, H-19), 1.05 (3H, s, H-13), 0.64 (3H, s, 
H-20). 13C-NMR δ (ppm): 185.3 (C-3), 150.8 
(C-15), 148.8 (C-4), 147.2 (C-2), 118.9 (C-
18), 118.2 (C-1), 108.9 (C-16), 55.5 (C-10), 
41.2 (C-5), 40.8 (C-8 & C-9), 39.4 (C-14), 
36.6 (C-6), 36.5 (C-13), 35.2 (C-11),33.9 (C-
19), 31.6 (C-12), 25.4 (C-7), 22.9 (C-17), 12.0 
(C-20). 
 
Tagalsin D (4) 
White solid. m.p. 64–66 OC;  
+38.4o (c0.074; CHCl3); IR (KBr) υmax 3406, 
3059, 2924, 2860, 1635, 1476, 1450, 1373, 
1264, 943 cm-1; EI-MS m/z (%): 304 [M]+ (5), 
289 (12), 274 (33), 259 (26), 241 (34), 189 
(25), 147 (32), 133 (46), 121 (51),107 (98); 
HRFABMS m/z 305.2474 [M + H]+ (calcd for 
C20H33O2, 305.2475).
 1H-NMR δ (ppm): 5.80 
(1H, dd, J = 17.5, 10.8 Hz, H-15), 4.90 (1H, d, 
J = 17.5 Hz, H-16b), 4.84 (1H, d, J = 10.8 Hz, 
H-16a), 3.45 (1H, dd, J = 2.0, 1.5, H-3), 3.08 
(1H, d, J = 4.6 Hz, H-18b), 2.72 (1H, d, J = 
4.6, H-18a), 2.15 (1H, m, H-2b), 2.04 (1H, 
ddd, J = 14.0, 4.5, 4.0 Hz, H-1b), 1.82 (1H, m
H-1a), 1.80 (1H, m, H-2a),  1.78 (1H, m, H-
11b), 1.59 (1H, ddd, J = 14.5, 3.0, 2.5 Hz, H-
6b), 1.47 (1H, ddd, J = 13.5, 13.5, 4.0, H-12b), 
1.39 (1H, m, H-10), 1.39 (3H, s, H-19). 1.33 
(1H, m, H-8), 1.32 (1H, dd, J = 13.0, 12.0 Hz, 
14b), 1.25 (1H, m, H-12a), 1.18 (1H, ddd, J = 
13.5, 13.5, 4.0 Hz, H-11a), 1.08 (1H, m H-
7b), 1.01 (3H, s, H-17), 0.99 (1H, m, H-7a), 
0.98 (1H, m, H-6a & H-14a), 0.87 (3H, s, H-
20). 13C-NMR δ (ppm): 151.2 (C-15), 108.8 
(C-16), 73.4 (C-3), 62.3 (C-4), 56.5 (C-18), 
54.7 (C-10), 41.8 (C-8), 38.9 (C-14), 37.4 (C-
9), 36.2 (C-13), 35.9 (C-5 & C-11), 34.4 (C-
6), 32.2 (C-12), 30.8 (C-19), 29.1 (C-2), 27.9 
(C-7), 22.8 (C-17), 16.8 (C-20), 15.7 (C-1). 
 
Tagalsin E (5) 
Yellow solid. m.p. 73–75 oC;  
+7.85o (c0.07, CHCl3); IR (KBr) υmax 2956, 
2923, 2860, 1692, 1636, 1607, 1457, 1377, 
908 cm-1; EI-MS m/z (%): 286 [M]+ (24), 271 
(22), 243 (22), 202 (30), 189 (25), 161 (27), 
149 (66), 121 (70),107 (100), 93 (88), 79 (85); 
HRFABMS m/z 287.2368 [M + H]+ (calcd for 
C20H31O, 287.2369).
 1H-NMR δ (ppm): 5.92 
(1H, brs, H-18a), 5.79 (1H, dd, J = 17.5, 10.8 





Hz, H-15), 5.24 (1H, brs, H-18b), 4.92 (1H, d, 
J = 17.5 Hz, H-16a), 4.84 (1H, d J = 10.8 Hz, 
H-16b), 2.00 (1H, m, H-1a), 2.11 (1H, m, H-
1b), 2.54 (1H, dd, J = 13.5, 5.0), 2.53 (1H, dd, 
J = 13.5, 8.5, H-2a), 2.15 (1H, m, H-6b), 1.69 
(1H, ddd, J = 13.0, 3.5, 3.5 Hz, H-11b), 1.52 
(1H, ddd, J = 13.0, 13.0, 3.5 Hz, H-12b), 1.48 
(1H, ddd, J = 15.0, 14.0, 2.5 Hz, H-16a), 1.40 
(1H, ddd, J = 11.5, 2.0, 2.0 Hz, H-10a), 1.34 
(1H, m, H-10b), 1.32 (1H, m, H-7b), 1.30 (1H, 
m, H-14b), 1.22 (1H, ddd, J = 13.0, 3.5, 3.0 
Hz, H-12a), 1.12 (1H, m, H-7a & H-11a), 1.08 
(3H, s, H-19), 1.02 (3H, s, H-17), 0.98 (1H, m, 
H-14a), 0.78 (3H, s, H-20). 13C-NMR δ (ppm): 
203.7 (C-3), 151.2 (C-15), 152.5 (C-4), 116.5 
(C-18)109.1 (C-16), 52.6 (C-10), 42.7 (C-8), 
41.2 (C-5), 39.2 (C-14), 38.4 (C-9), 37.6 (C-
6), 36.7 (C-2), 36.6 (C-13),  35.8 (C-11), 33.8 
(C-19), 32.1 (C-12), 25.8 (C-7), 23.2 (C-17), 
18.0 (C-1), 13.9 (C-20). 
 
Tagalsin F (6) 
White solid. m.p. 98–99 oC;  
+34.86o (c0.072; CHCl3); IR (KBr) υmax 3084, 
2967, 2922, 2857, 1622, 1455, 1384, 1188 cm-
1; EI-MS m/z (%): 303 [M + H]+; HRFABMS 
m/z 303.2319 [M + H]+ (calcd for C20H31O2, 
303.2318). 1H-NMR δ (ppm): 7.90 (1H, d, J = 
7.8, H-18), 5.78 (1H, dd, J = 17.5, 10.7 Hz, H-
15), 4.88 (1H, d, J = 17.5 Hz, H-16a), 4.84 
(1H, d, J = 10.7 Hz, H-16b), 2.46 (1H, dd, J = 
13.0, 3.0 Hz, H-2a), 2.45 (1H, dd, J = 13.0, 
9.0 Hz, H-2b),  2.13 (1H, ddd, J = 14.0, 4.0, 
3.0 Hz, H-6b), 2.04 (1H, ddd, J = 16.5, 9.0, 
7.0 Hz, H-1b),  1.97 (1H, m, H-1a), 1.62 (1H, 
ddd, J = 13.0, 4.0, 3.0 Hz, H-11b), 1.53 (1H, 
ddd, J = 14.0, 14.0, 4.0 Hz, H-12b), 1.42 (1H, 
ddd, J = 14.0, 13.0, 4.0 Hz, H-6a), 1.41 (1H, 
ddd, J = 13.5, 13,0, 3.5 Hz, H-11a), 1.32 (1H, 
dd, J = 13.5, 13.0 Hz, 14b), 1.24 (1H, m, H-
10), 1.23 (1H, m, H-7b), 1.20 (1H, ddd, J = 
14.0, 3.5, 3.0 Hz, H-12a), 1.15 (3H, s, H-19), 
1.10 (1H, m, H-7a), 1.01 (3H, s, H-17), 0.96 
(1H, ddd, J = 13.5, 1.5, 1.5 Hz, H-14a), 0.69 
(3H, s, H-20). 13C-NMR δ (ppm): 199.6 (C-3), 
171.2 (C-18), 150.9 (C-15), 116.7 (C-4), 108.8 
(C-16), 51.8 (C-10), 42.5 (C-8), 38.8 (C-14), 
37.7 (C-9), 36.7 (C-6), 36.3 (C-5), 36.1 (C-
13), 35.8 (C-19), 35.2 (C-11), 31.7 (C-12), 
31.5 (C-2), 25.5 (C-7), 23.0 (C-17), 16.1 (C-
1), 12.7 (C-20). 
 
Tagalsin G (7) 
Colorless oil;  +55.97o 
(c0.09;CHCl3); IR (KBr) υmax 3429, 2924, 
2857, 1732, 1667, 1640, 1451, 1394, 1201, 
1101 cm-1; EI-MS m/z (%): 302 [M]+ (8), 287 
(43), 263 (53), 203 (100), 149 (73), 107 (89), 
93 (55), 81 (56); HRFABMS m/z 303.2319 
[M+ H] + (calcd for C20H31O2, 303.2318).
 1H-
NMR δ (ppm): 5.81 (1H, dd, J = 17.5, 10.8 
Hz, H-15), 4.94 (1H, d, J = 17.5 Hz, H-16a), 
4.87 (1H, d, J = 10.8 Hz, H-16b), 2.87 (1H, 
dd, J = 18.7, 6.5 Hz, H-1b), 2.77 (1H, d J = 
18.7 Hz, H-1a), 2.19 (1H, ddd, J = 13.5, 2.5, 
2.5 Hz, H-6b), 1.90 (3H, s, H-18), 1.68 (1H, d, 
J = 6.5 Hz, H-10), 1.66 (1H, ddd, J = 13.5, 
3.5, 3.5, H-11b), 1.54 (1H, ddd, J = 13.5, 13.5, 
4.0 Hz, H-12b), 1.53 (1H, m, 7b), 1.41 (1H, m, 
H-8), 1.40 (1H, dd, J = 13.5, 13.0 Hz, H-14b), 
1.30 (1H, m, H-6a), 1.27 (3H, s, H-19), 1.21 
(1H, ddd, J = 13.5, 4.0, 3.5 Hz, H-12a), 1.18 
(1H, m, H-7a), 1.12 (1H, ddd, J = 13.5, 13.5 
Hz, 4.0 Hz, H-11a), 1.05 (3H, s H-17), 1.02 
(1H, m, H-14a), 0.62 (3H, s, H-20). 13C-NMR 
δ (ppm): 193.1 (C-2), 150.9 (C-15), 144.5 (C-
3), 135.5 (C-4), 108.9 (C-16), 54.5 (C-10), 
41.6 (C-8), 39.0 (C-5), 38.9 (C-14),  38.1 (C-
9), 38.0 (C-6), 36.2 (C-13), 34.2 (C-11), 33.2 
(C-1), 31.7 (C-12), 31.6 (C-19), 26.7 (C-7), 
23.1 (C-17), 13.7 (C-20), 11.6 (C-18).  
 
Caspase-3-activity 
Caspase- 3 calorimetric assay was used 
to measure the protease activity of caspase 3 
under the activation of seven dolaboranes 
namely tagalsins 1, 2, 3, 4, 5, 6 and 7. The 
procedure reported by Chacha (2011) was 
adopted with minor modification. 
 






The chromatographic analyses of the 
chloroform extracts from the roots of Ceriops 
tagal yielded seven dolaborane-diterpenes 
identified as tagalsins A (1), B (2), C (3), D 
(4), E (5), F (6) and G (7) (Fig 1). The 
chemical structures of these compounds were 
established on the basis of IR, MS and NMR 
spectral data and in comparison with the 
existing data in literature (Zhang et al., 2005).  
Tagalsins A – G (1 – 7) were evaluated 
for the activation caspase-3 enzyme in 
cleaving p-nitroaniline from acetyl-Asp-Glu-
Val-Asp p-nitroanilide (Ac-DEVD-pNA) in 
the presence of the caspase-3 inhibitor Ac-
DEVD-CHO. The released p-NA was detected 
microplate reader set at 405 nm (εmM = 10.5) 
and the concentration of the released p-NA 
was calculated from the absorbance mean 
values. The minimum activation concentration 
(MAC) of the compounds was established. 
The cleavage of the caspase-3-specific 
colorimetric substrate (DEVD-pNA) was 
therefore considered to represent caspase-3 
activity.  
Tagalsins A - G activated caspase-3 
activity in cleaving p-NA from Ac-DEVD-
pNA which is an important biochemical step 
for the execution of apoptosis. Tagalsin A (1)
was the most active followed by tagalsin B (2)
and tagalsin E (5) was the least active (Table 
1). The minimum activation concentration 
(MAC) of tagalsins A - G (1 - 7) were 0.12, 
0.15, 0.43, 0.25, 1.16, 0.54 and 0.62 mg/ml 
which gave 81.4, 72.5, 32.8, 68.4, 13.7, 27.1 
and 24.6 µmol/ml of cleaved P-NA 
respectively. These compounds were tested for 
in vitro cytotoxicity against cultured human 
tumor cell lines H-60, Bel-7402 and Hela, they 
did not show any activity (Zhang et al, 2005). 
The anticancer activity exhibited in this study 
indicates that tagalsins A – G are specific in 
action and thus offers an avenue for the 
development of novel anticancer agents. This 
is the first time for tagalsins A – G to be 
evaluated for the induction of apoptosis 




































Figure 1: Structures of tagalsin A (1), B (2), C (3), D (4), E (5), F (6) and G (7). 





Table 1:  Minimum activation concentration (MAC) of compounds 1, 2, 3, 4, 5, 6 and 7 with the 











The available anticancer agents are 
mostly targeting processes that cancer cells use 
to grow and divide, such as the ability of the 
cells to replicate their deoxyribose nucleic acid 
(Malpas, 1997; Chen et al., 2000; Braybroke et 
al., 2003; Usui et al., 2004; Dias et al., 2005; 
Kamal et al., 2005). With the establishment 
that cancerous cells produces proteins that 
blocks the process of apoptosis, the 
development of compounds that activates the 
apoptosis of cancerous cells has emerged as a 
powerful strategy in the fight against cancer. 
Thus, tagalsins A – G (1 – 7) isolated from the 
roots of Ceriops tagal were tested for the 
induction of caspase-3 enzyme in the activation 
of apoptotic pathway. The difference in the 
activity exhibited by these compounds is 
probably due to the difference in their 
structures (Figure 1 and Table 1).  
Structure activity relationship has 
revealed that epoxide rings and oxygen atoms 
are important in the activation of caspase-3. 
This was proved by the high activity exhibited 
by tagalsins A (1) and B (2) which posses 
epoxide rings and two oxygen atoms each. 
Tagalsin D (4) which has an epoxide ring and 
one hydroxyl group displayed higher activity 
than tagalsins C (3), E (5), F (6) and G (7). 
Tagalsin E (5) which has only one oxygen 
atom was the least active proving the 
importance of oxygen atoms in the activity of 
dolaboranes. The present study corroborates a 
previous report that oxygenation enhance the 
activity of isopimaranes in inducing caspase-3 
enzyme in the activation of apoptotic pathways 
(Chacha, 2011). This is the first time for 
tagalsins 1 – 7 to be evaluated for the induction 




Chemotherapeutic agents based on 
natural products have been the backbone of 
healthcare systems for all communities since 
ancient times, and indeed the treatment of 
cancer has relied heavily on therapeutics based 
on natural products and their analogues. This 
study has established that dolaboranes from the 
roots of Ceriops tagal induces caspase-3 
activity in activating apoptosis in cancerous 
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